Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

NUVARING

CompanyA-S Medication Solutions (DUNS: 830016429)

Effective Date

April 14, 2021

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Etonogestrel(0.12 mg in 1 d)

Ethinylestradiol(0.015 mg in 1 d)

Manufacturing Establishments (1)

A-S Medication Solutions

Labeler

A-S Medication Solutions

DUNS Number

830016429

Products (1)

NUVARING

NDC Product Code

50090-1008

Application Number

NDA021187

Marketing Category

NDA (C73594)

Route of Administration

VAGINAL

Effective Date

January 24, 2020

Ingredients

EtonogestrelActive

Code: 304GTH6RNHClass: ACTIBQuantity: 0.12 mg in 1 d

EthinylestradiolActive

Code: 423D2T571UClass: ACTIBQuantity: 0.015 mg in 1 d

ethylene-vinyl acetate copolymer (28% vinyl acetate)Inactive

Code: 8ILA5X28VSClass: IACT

ethylene-vinyl acetate copolymer (9% vinylacetate)Inactive

Code: 4OKC630HS6Class: IACT

magnesium stearateInactive

Code: 70097M6I30Class: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy